Revelation Biosciences (NASDAQ:REVB) files preliminary prospectus resale of up to 14,224,140 shares of common stock by the selling stockholders. SEC Filing

More on Revelation Biosciences

Seeking Alpha's Quant Rating on Revelation Biosciences Historical earnings data for Revelation Biosciences Financial information for Revelation Biosciences